Global Pet Tick and Flea Prevention Market 2024-2031

Global Pet Tick and Flea Prevention Market 2024-2031

Pet Tick and Flea Prevention Market Size, Share & Trends Analysis Report by Product Type (Oral Pills, Spray, Spot On, Powder, Shampoo, and Other), by Animals (Dogs, Cats, and Other Animals), and by Sales Channel (Online Channel, and Offline Channel) Forecast Period (2024-2031)

Pet tick and flea prevention market is anticipated to grow at a CAGR of 9.5% during the forecast period (2024-2031). Ticks and fleas are common environmental parasites and insects that typically infect dogs and cats. Fleas are important in the spread of parasites that can irritate and sicken pets, including roundworms, tapeworms, and bacterial infections. Ticks are extremely dangerous for pets as they can spread illnesses like Lyme disease. The growing cases of illness and sickness in the pet population is a key factor driving the global market demand.

Market Dynamics

A rising pet ownership to boost the market growth

According to the International Veterinary Medical Association, as of 2024, 66.0% of US households (86.9 million homes) own a pet. Dogs are the most popular pets, with 65.1 million households owning one, followed by cats (46.5 million households). The rising pet ownership globally is likely to drive demand for tick and flea-preventive products. This is due to the growing pet humanization and a rising pet welfare cost. In addition, the growing government campaigns to educate the public about pet fleas and ticks and how to prevent them are further aiding the global market growth.

Market Segmentation

Based on product type, the market is segmented into oral pills, spray, spot-on, powder, shampoo, collar, and others.

Based on animals, the market is segmented into dogs, cats, and other animals (mice, rats).

Based on sales channels, the market is segmented into online channels and offline channels.

Dogs Segment to Hold a Considerable Market Share

Dogs are highly vulnerable to diseases caused by ticks and fleas. The high population of dog owners has made substantial contributions to the market expansion for pet tick and flea control. Dog owners are highly inclined towards the adoption of these preventative products to shield their dogs from potentially fatal illnesses including allergies and infections.

Regional Outlook

The global pet tick and flea prevention market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

Asia-Pacific countries to invest in animal healthcare

India's tropical climate makes it easier for diseases carried by ticks and fleas to spread among dogs, cats, and other animals which increases the product demand.

The increasing usage of flea and tick repellents is contributing to the safety and significance of coexisting humans and pets.

North America Holds Major Market Share

The high adoption rate of companion animals, high disposable income, and rising per capita costs associated with animal healthcare are the key contributors to the high share of the regional market growth. According to a survey led by Wellbeing International, the US was home to 135 million dogs and cats in 2021. The awareness among the population regarding the availability and benefits of these products is further aiding the regional market growth. Furthermore, as pet adoption rises in the area, so does the availability of pet insurance, which is predicted to fuel the flea and tick market's expansion.

Market Players Outlook

The major companies serving the global pet tick and flea prevention market include Boehringer Ingelheim Group, Ceva Sante Animale S.A., Ecto Development Corp., Eli Lilly & Company, and Merck & Co., Inc., among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions to stay competitive in the market. For instance, in August 2023, Boehringer Ingelheim launched the NexGard (afoxolaner) S and M in the Indian market. The successful 2020 launch of NexGard X and L has led to an expansion of the NexGard product line.